BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6739517)

  • 1. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic adaptations to chronic oxotremorine infusion.
    Marks MJ; Artman LD; Patinkin DM; Collins AC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ; Romm E; Collins AC
    Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
    Ben-Barak J; Gazit H; Silman I; Dudai Y
    Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents.
    Costa LG; Kaylor G; Murphy SD
    Int J Immunopharmacol; 1990; 12(1):67-75. PubMed ID: 2303319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
    Costa LG; Schwab BW; Murphy SD
    Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice.
    Collins AC; Campbell SM; Romm E; Marks MJ
    Alcohol Clin Exp Res; 1990 Aug; 14(4):605-15. PubMed ID: 2221290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic drug effects and brain muscarinic receptor binding in aged rats.
    Pedigo NW; Minor LD; Krumrei TN
    Neurobiol Aging; 1984; 5(3):227-33. PubMed ID: 6514108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain.
    Lerer B; Stanley M
    Brain Res; 1985 Oct; 344(2):211-9. PubMed ID: 4041871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
    Smolen TN; Smolen A; Collins AC
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraction and [3H]QNB binding in collagenase isolated fundic smooth muscle cells.
    Seidel ER; Johnson LR
    Am J Physiol; 1983 Aug; 245(2):G270-6. PubMed ID: 6881350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of tolerance development after chronic oxotremorine treatment.
    Marks MJ; Artman LD; Collins AC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):103-13. PubMed ID: 6622504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical studies of oxiracetam (CT-848) on cholinergic neurons].
    Mochizuki D; Sugiyama S; Shinoda Y
    Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):27-35. PubMed ID: 1559636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically-determined responses of central cholinergic markers: the effects of ethanol on inbred strains of mice.
    Hashemzadeh-Gargari H; Mandel P
    Neurotoxicology; 1989; 10(3):555-68. PubMed ID: 2626217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
    Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression.
    Overstreet DH; Daws LC; Schiller GD; Orbach J; Janowsky DS
    Pharmacol Biochem Behav; 1998 Apr; 59(4):777-85. PubMed ID: 9586831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.